Dysferlinopathy
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy (LGMD R2) in the RF (NCT04824040) | Artgen Biotech | 2020-01-15 |
| rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies (NCT02710500) | Sarepta Therapeutics, Inc. | 2016-03-01 |
| Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin (NCT01863004) | University Hospital, Basel, Switzerland | 2012-12-01 |
| Clinical Outcome Study for Dysferlinopathy (NCT01676077) | Newcastle-upon-Tyne Hospitals NHS Trust | 2012-09-01 |
Track Dysferlinopathy automatically
Every clearance here is in the API, with alerts when new ones post.